These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22210869)

  • 1. Small-molecule inhibitor starting points learned from protein-protein interaction inhibitor structure.
    Koes DR; Camacho CJ
    Bioinformatics; 2012 Mar; 28(6):784-91. PubMed ID: 22210869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fast Rescoring Protocols to Improve the Performance of Structure-Based Virtual Screening Performed on Protein-Protein Interfaces.
    Singh N; Chaput L; Villoutreix BO
    J Chem Inf Model; 2020 Aug; 60(8):3910-3934. PubMed ID: 32786511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of α-helix-mediated protein-protein interactions using designed molecules.
    Azzarito V; Long K; Murphy NS; Wilson AJ
    Nat Chem; 2013 Mar; 5(3):161-73. PubMed ID: 23422557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving small molecule virtual screening strategies for the next generation of therapeutics.
    Wingert BM; Camacho CJ
    Curr Opin Chem Biol; 2018 Jun; 44():87-92. PubMed ID: 29920436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors.
    Li B; Rong D; Wang Y
    Curr Top Med Chem; 2019; 19(21):1872-1876. PubMed ID: 31696799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.
    Arkin MR; Tang Y; Wells JA
    Chem Biol; 2014 Sep; 21(9):1102-14. PubMed ID: 25237857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simplified quality assessment for small-molecule ligands in the Protein Data Bank.
    Shao C; Westbrook JD; Lu C; Bhikadiya C; Peisach E; Young JY; Duarte JM; Lowe R; Wang S; Rose Y; Feng Z; Burley SK
    Structure; 2022 Feb; 30(2):252-262.e4. PubMed ID: 35026162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting protein-protein interactions and fragment-based drug discovery.
    Valkov E; Sharpe T; Marsh M; Greive S; Hyvönen M
    Top Curr Chem; 2012; 317():145-79. PubMed ID: 22006238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of protein-protein interactions (PPIs): an analysis of scaffold choices and buried surface area.
    Ran X; Gestwicki JE
    Curr Opin Chem Biol; 2018 Jun; 44():75-86. PubMed ID: 29908451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HADDOCK(2P2I): a biophysical model for predicting the binding affinity of protein-protein interaction inhibitors.
    Kastritis PL; Rodrigues JP; Bonvin AM
    J Chem Inf Model; 2014 Mar; 54(3):826-36. PubMed ID: 24521147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AlphaSpace: Fragment-Centric Topographical Mapping To Target Protein-Protein Interaction Interfaces.
    Rooklin D; Wang C; Katigbak J; Arora PS; Zhang Y
    J Chem Inf Model; 2015 Aug; 55(8):1585-99. PubMed ID: 26225450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stabilization of protein-protein interaction complexes through small molecules.
    Zarzycka B; Kuenemann MA; Miteva MA; Nicolaes GAF; Vriend G; Sperandio O
    Drug Discov Today; 2016 Jan; 21(1):48-57. PubMed ID: 26434617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice.
    Park D; Park CW; Choi Y; Lin J; Seo DH; Kim HS; Lee SY; Kang IC
    Biomaterials; 2016 Aug; 98():131-42. PubMed ID: 27187277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benchmark Study Based on 2P2I
    Wang Z; Kang Y; Li D; Sun H; Dong X; Yao X; Xu L; Chang S; Li Y; Hou T
    J Phys Chem B; 2018 Mar; 122(9):2544-2555. PubMed ID: 29420886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domain-based small molecule binding site annotation.
    Snyder KA; Feldman HJ; Dumontier M; Salama JJ; Hogue CW
    BMC Bioinformatics; 2006 Mar; 7():152. PubMed ID: 16545112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational probing protein-protein interactions targeting small molecules.
    Wang YC; Chen SL; Deng NY; Wang Y
    Bioinformatics; 2016 Jan; 32(2):226-34. PubMed ID: 26415726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing focused chemical libraries enriched in protein-protein interaction inhibitors using machine-learning methods.
    Reynès C; Host H; Camproux AC; Laconde G; Leroux F; Mazars A; Deprez B; Fahraeus R; Villoutreix BO; Sperandio O
    PLoS Comput Biol; 2010 Mar; 6(3):e1000695. PubMed ID: 20221258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Training based on ligand efficiency improves prediction of bioactivities of ligands and drug target proteins in a machine learning approach.
    Sugaya N
    J Chem Inf Model; 2013 Oct; 53(10):2525-37. PubMed ID: 24020509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-Directed Synthesis of Inhibitors of the p53/hDM2 Protein-Protein Interaction.
    Green AI; Hobor F; Tinworth CP; Warriner S; Wilson AJ; Nelson A
    Chemistry; 2020 Aug; 26(47):10682-10689. PubMed ID: 32458465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.